At Novum, integrity is everything.

You expect it from your research partners. We demand it in the studies we design, conduct and manage and in how we work with you.



Trust 40-plus years of industry experience. Novum is a full-service CRO with numerous FDA approvals in ANDA and NDA submissions. We conduct more than 250 studies a year across multiple therapeutic areas and have developed long-standing relationships with a wide range of global sponsors who rely on our Early Phase Research and Clinical Trial Management expertise. Read More »


Novum provides a full spectrum of services in managing multicenter Clinical Endpoint Studies and in conducting Early Phase Studies in our Novum facilities, from protocol design to final report. We offer reliable, turnkey solutions for your drug development program and ensure that every service we perform is designed to provide timely output of the high-quality data your study demands.

Read More »